| mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
-0.0065 |
1 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
| mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.0016 |
1 |
| mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
| mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.00076 |
1 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00086 |
1 |
| mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.00085 |
1 |
| mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.0012 |
1 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00076 |
1 |